Daily consumption of ultra-high hydrostatic pressurized brown rice improves cognitive, mental, and bone health in the elderly: A 12-month, single blind, parallel-group randomized trial
Author:
Matsuzaki Kentaro1, Yano Shozo1, Kuroda Yoko1, Tanabe Yoko1, Nakahata Hiroko2, Matsuda Tatsushi3, Kinoshita Hitoshi3, Yoshino Katsumi4, Shido Osamu5, Kishi Hiroko1, Hashimoto Michio1
Affiliation:
1. Shimane University 2. PLUS Co., Ltd. 3. Satoyama food Co., Ltd. 4. Shimane Institute for Industrial Technology 5. Shimane rehabilitation college
Abstract
Abstract
Purpose
Age-related cognitive and psychiatric impairments are related to bone fragility. We reported that ultra-high hydrostatic pressurized brown rice (UBR) consumption helps maintain cognitive function and bone mineral density (BMD), but their association remains unexplored. This study evaluated the effects of UBR consumption for 12 months on cognitive and mental function and their association with BMD in the elderly.
Methods
Fortyfour participants (65–85 years) were randomly assigned to either the white rice (WR) (n = 22) or UBR (n = 22) group, and received 200 g of WR or 100 g of UBR and 100 g of WR daily for 12 months, respectively. At baseline and 12-month, Mini-Mental State Examination (MMSE) and Cognitive Assessment for Dementia, iPad version (CADi) measured cognitive function. Apathy and depression were assessed using the Starkstein apathy scale and Zung’s self-rated depression scale (SDS), respectively. Calcaneal BMD was measured using an ultrasound bone densitometer and converted to percentage of the Young-Adult Mean (%YAM).
Results
Twenty participants in each of the WR and UBR group completed the 12-month trial with high adherence. Twelve-month of UBR intake significantly improved MMSE, CADi, Starkstein apathy scores, and %YAM in the elderly compared to WR intake. In addition, CADi, apathy, and SDS scores were significantly correlated with bone health index %YAM. No adverse events were attributed to the intervention.
Conclusion
These results suggest that daily UBR consumption may improve age-related cognitive and mental impairments, and retained BMD; potentially combating dementia and osteoporosis in the elderly.
Clinical trials registration:
This study was retrospectively registered in Februaly 9th 2024, at UMIN Clinical Trials Registry as UMIN000053587.
Publisher
Research Square Platform LLC
Reference63 articles.
1. 1. Arvanitakis Z, Shah RC, Bennett DA (2019) Diagnosis and management of dementia: Review: review. JAMA 322:1589–1599. https://doi.org/10.1001/jama.2019.4782. 2. 2. Mehta K, Thandavan SP, Mohebbi M, Pasco JA, Williams LJ, Walder K, Ng BL, Gupta VB (2022) Depression and bone loss as risk factors for cognitive decline: A systematic review and meta-analysis. Ageing Res Rev 76:101575. https://doi.org/10.1016/j.arr.2022.101575. 3. 3. Xiao T, Ghatan S, Mooldijk SS, Trajanoska K, Oei L, Gomez MM, Ikram MK, Rivadeneira F, Ikram MA (2023) Association of bone mineral density and dementia: the Rotterdam study. Neurology 100:e2125–e2133. https://doi.org/10.1212/WNL.0000000000207220. 4. 4. Filler J, Georgakis MK, Dichgans M (2024) Risk factors for cognitive impairment and dementia after stroke: a systematic review and meta-analysis. Lancet Healthy Longev 5:e31–e44. https://doi.org/10.1016/S2666-7568(23)00217-9. 5. 5. Ruggiero C, Baroni M, Xenos D, Parretti L, Macchione IG, Bubba V, Laudisio A, Pedone C, Ferracci M, Magierski R, Boccardi V, Antonelli-Incalzi R, Mecocci P (2024) Dementia, osteoporosis and fragility fractures: intricate epidemiological relationships, plausible biological connections, and twisted clinical practices. Ageing Res Rev 93:102130. https://doi.org/10.1016/j.arr.2023.102130.
|
|